Replies to post #10134 on RespireRx Pharmaceuticals Inc (RSPI)

[money4retirement]

well i had typed the best reply ever written. before i clicked submit my pc crashed. (really, it did.)

so i don't want to do it all over again.

so i'll be very brief.

8/24 pipe - big pps drop.

conf call a few days ago with somewhat good stuff; but none of the new stuff mentioned will be happening soon.

the next major event will be the fda decision on the company's ADHD cx717 ind, due 10/11/07.

if approved, $3 very soon thereafter, around $4 not to long after. then a BP partnership for the ADHD ampakine compound cx717 within 6 mo, pps $6.00, maybe $8; it depends on how the deal is structured. (i'm giving you the general consensus.)

if the fda does not approve the ind. well i can always be a part time dishwasher.


fred